litlas
Log inCreate account

Michael A. Vogelbaum

Active 1998–2025

Also published as
Michael A Vogelbaum
179
Papers
31,284
Citations
94
h-index
172
i10-index

Citations

Citations per year for Michael A. Vogelbaum1993: 2 citations1999: 2 citations2000: 4 citations2001: 4 citations2002: 4 citations2003: 9 citations2004: 10 citations2005: 14 citations2006: 15 citations2007: 20 citations2008: 46 citations2009: 42 citations2010: 78 citations2011: 123 citations2012: 125 citations2013: 167 citations2014: 220 citations2015: 266 citations2016: 262 citations2017: 332 citations2018: 269 citations2019: 1,025 citations2020: 1,335 citations2021: 1,356 citations2022: 1,202 citations2023: 1,009 citations2024: 1,784 citations2025: 1,010 citations2026: 46 citations1994–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,593 citing papers, 27.5% of this breakdownChina: 1,250 citing papers, 9.6% of this breakdownGermany: 1,048 citing papers, 8% of this breakdownUnited Kingdom: 686 citing papers, 5.3% of this breakdownItaly: 658 citing papers, 5% of this breakdownFrance: 550 citing papers, 4.2% of this breakdownCanada: 508 citing papers, 3.9% of this breakdownNetherlands: 506 citing papers, 3.9% of this breakdownSwitzerland: 444 citing papers, 3.4% of this breakdownSpain: 331 citing papers, 2.5% of this breakdownJapan: 292 citing papers, 2.2% of this breakdownSouth Korea: 265 citing papers, 2% of this breakdown
0%27.5%Other 22.5%

Institutions

Fields

  • Medicine70.4%
  • Biochemistry, Genetics and Molecular Biology13%
  • Immunology and Microbiology5.9%
  • Neuroscience3.1%
  • Computer Science2.1%
  • Engineering1.9%
  • Other3.6%

Topics

  • Glioma Diagnosis and Treatment17.5%
  • Brain Metastases and Treatment8.4%
  • Meningioma and schwannoma management4.2%
  • Radiomics and Machine Learning in Medical Imaging3.2%
  • Immune cells in cancer2.3%
  • Lung Cancer Research Studies2.1%
  • Other62.3%

Coauthors

All papers

Open in search
  1. Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

    Authors: Patrick Y. Wen, David R. Macdonald, David A. Reardon, Timothy F. Cloughesy, A. Gregory Sorensen, Evanthia Galanis, John DeGroot, Wolfgang Wick, Mark R. Gilbert, Andrew B. Lassman, Christina Tsien, Tom Mikkelsen, Eric T. Wong, Marc C. Chamberlain, Roger Stupp, Kathleen R. Lamborn, Michael A. Vogelbaum, Martin J. van den Bent, Susan M. Chang - Journal of Clinical Oncology 2010 cited by 3,829

  2. Federated learning enables big data for rare cancer boundary detection

    Authors: Sarthak Pati, Ujjwal Baid, Brandon Edwards, Micah Sheller, Shih‐Han Wang, G. Anthony Reina, Patrick Foley, А. Д. Груздев, Deepthi Karkada, Christos Davatzikos, Chiharu Sako, Satyam Ghodasara, Michel Bilello, Suyash Mohan, Philipp Kickingereder, Gianluca Brugnara, Chandrakanth Jayachandran Preetha, Felix Sahm, Klaus Maier‐Hein, Maximilian Zenk, Martin Bendszus, Wolfgang Wick, Evan Calabrese, Jeffrey D. Rudie, Javier Villanueva‐Meyer, Soonmee Cha, Madhura Ingalhalikar, Manali Jadhav, Umang Pandey, Jitender Saini, John W. Garrett, Matthew Larson, Robert Jeraj, Stuart Currie, Russell Frood, Kavi Fatania, Raymond Y. Huang, Ken Chang, Carmen Balañá, Jaume Capellades, Josep Puig, Johannes Trenkler, Josef Pichler, Georg Necker, Andreas Haunschmidt, Stephan Meckel, Gaurav Shukla, Spencer Liem, Gregory S. Alexander, Joseph S. Lombardo, Joshua D. Palmer, Adam E. Flanders, Adam P. Dicker, Haris I. Sair, Craig Jones, Archana Venkataraman, Meirui Jiang, Tiffany Y. So, Cheng Chen, Pheng‐Ann Heng, Qi Dou, Michal Kozubek, Filip Lux, Jan Michálek, Petr Matula, Miloš Keřkovský, Tereza Kopřivová, Marek Dostál, Václav Vybíhal, Michael A. Vogelbaum, J. Ross Mitchell, Joaquim M. Farinhas, Joseph A. Maldjian, Chandan Ganesh Bangalore Yogananda, Marco C. Pinho, Divya Reddy, James Holcomb, Benjamin Wagner, Benjamin M. Ellingson, Timothy F. Cloughesy, Catalina Raymond, Talia C. Oughourlian, Akifumi Hagiwara, Chencai Wang, Minh‐Son To, Sargam Bhardwaj, Chee Chong, Marc Agzarian, Alexandre X. Falcão, Samuel Botter Martins, Bernardo Corrêa de Almeida Teixeira, F Sprenger, David Menotti, Diego Rafael Lucio, Pamela LaMontagne, Daniel S. Marcus, Benedikt Wiestler, Florian Kofler, Ivan Ezhov, Marie Metz and 179 more - Nature Communications 2022 cited by 340

  3. A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

    Authors: Mark R. Gilbert, James J. Dignam, Terri S. Armstrong, Jeffrey S. Wefel, Deborah T. Blumenthal, Michael A. Vogelbaum, Howard Colman, Arnab Chakravarti, Stephanie L. Pugh, Minhee Won, Robert Jeraj, Paul D. Brown, Kurt A. Jaeckle, David Schiff, Volker W. Stieber, David Brachman, Maria Werner‐Wasik, Ivo W. Tremont‐Lukats, Erik P. Sulman, Kenneth Aldape, Walter J. Curran, Minesh P. Mehta - New England Journal of Medicine 2014 cited by 2,793

  4. RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults

    Authors: Patrick Y. Wen, Martin J. van den Bent, Gilbert Youssef, Timothy F. Cloughesy, Benjamin M. Ellingson, Michael Weller, Evanthia Galanis, Daniel P. Barboriak, John de Groot, Mark R. Gilbert, Raymond Y. Huang, Andrew B. Lassman, Minesh P. Mehta, Annette M. Molinaro, Matthias Preusser, Rifaquat Rahman, Lalitha Shankar, Roger Stupp, Javier Villanueva-Meyer, Wolfgang Wick, David R. Macdonald, David A. Reardon, Michael A. Vogelbaum, Susan M. Chang - Journal of Clinical Oncology 2023 cited by 462

  5. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial

    Authors: Farshad Nassiri, Vikas Patil, Leeor Yefet, Olivia Singh, Jeff Liu, Rachel M. A. Dang, Takafumi N. Yamaguchi, Mariza Daras, Timothy F. Cloughesy, Howard Colman, Priya Kumthekar, Clark C. Chen, Robert Aiken, Morris D. Groves, Shirley Ong, Rohan Ramakrishna, Michael A. Vogelbaum, Simon Khagi, Thomas Kaley, Jason M. Melear, David M. Peereboom, Analiz Rodriguez, Maxim Yankelevich, Suresh Nair, Vinay K. Puduvalli, Kenneth Aldape, Andrew Gao, Álvaro López‐Janeiro, Carlos E. de Andrea, Marta M. Alonso, Paul C. Boutros, Joan M. Robbins, Warren Mason, Adam M. Sonabend, Roger Stupp, Juàn Fueyo, Candelaria Gomez‐Manzano, Frederick F. Lang, Gelareh Zadeh - Nature Medicine 2023 cited by 270

  6. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline

    Authors: Michael A. Vogelbaum, Paul D. Brown, Hans Messersmith, Priscilla K. Brastianos, Stuart H. Burri, Daniel P. Cahill, Ian F. Dunn, Laurie E. Gaspar, Na Tosha Gatson, Vinai Gondi, Justin T. Jordan, Andrew B. Lassman, Julia Maués, Nimish Mohile, Navid Redjal, Glen Stevens, Erik P. Sulman, Martin J. van den Bent, H. James Wallace, Jeffrey S. Weinberg, Gelareh Zadeh, David Schiff - Journal of Clinical Oncology 2021 cited by 798

  7. Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma

    Authors: Alessandra De Leo, Alessio Ugolini, Xiaoqing Yu, Fabio Scirocchi, Delia Scocozza, Bárbara Peixoto, Angelica Pace, Luca D’Angelo, James K. Liu, Arnold B. Etame, Aurelia Rughetti, Marianna Nuti, Antonio Santoro, Michael A. Vogelbaum, José R. Conejo-García, Paulo C. Rodrı́guez, Filippo Veglia - Immunity 2024 cited by 260

  8. Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group

    Authors: Philipp Karschnia, Jacob S. Young, Antonio Dono, Levin Häni, Tommaso Sciortino, Francesco Bruno, Stephanie T Juenger, Nico Teske, Ramin A. Morshed, Alexander F. Haddad, Yalan Zhang, Sophia Stoecklein, Michael Weller, Michael A. Vogelbaum, Jürgen Beck, Nitin Tandon, Shawn L. Hervey‐Jumper, Annette M. Molinaro, Roberta Rudà, Lorenzo Bello, Oliver Schnell, Yoshua Esquenazi, Maximilian I. Ruge, Stefan Grau, Mitchel S. Berger, Susan M. Chang, Martin J. van den Bent, Joerg‐Christian Tonn - Neuro-Oncology 2022 cited by 343

  9. Response assessment criteria for brain metastases: proposal from the RANO group

    Authors: Nancy U. Lin, Eudocia Q. Lee, Hidefumi Aoyama, Igor J. Barani, Daniel P. Barboriak, Brigitta G. Baumert, Martin Bendszus, Paul D. Brown, D. Ross Camidge, Susan M. Chang, Janet Dancey, Elisabeth G.E. de Vries, Laurie E. Gaspar, Gordon J. Harris, F. Stephen Hodi, Steven N. Kalkanis, Mark E. Linskey, David Macdonald, Kim Margolin, Minesh P. Mehta, David Schiff, Riccardo Soffietti, John H. Suh, Martin J. van den Bent, Michael A. Vogelbaum, Patrick Y. Wen - The Lancet Oncology 2015 cited by 1,088

  10. Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study

    Authors: Martin J. van den Bent, C. Mircea S. Tesileanu, Wolfgang Wick, Marc Sanson, Alba A. Brandes, Paul M. Clément, S. C. Erridge, Michael A. Vogelbaum, Anna K. Nowak, Jean Français Baurain, Warren Mason, Helen Wheeler, Olivier Chinot, Sanjeev Gill, Matthew Griffin, Leland Rogers, Walter Taal, Roberta Rudà, Michael Weller, Catherine McBain, Jaap C. Reijneveld, Roelien H. Enting, Francesca Caparrotti, Thierry Lesimple, Susan Clenton, Anja Gijtenbeek, Elizabeth Lim, Ulrich Herrlinger, Peter Hau, F. Dhermain, Iris de Heer, Kenneth Aldape, Robert B. Jenkins, Hendrikus J. Dubbink, Johan M. Kros, Pieter Wesseling, Sarah Nuyens, Vassilis Golfinopoulos, Thierry Gorlia, Pim J. French, Brigitta G. Baumert - The Lancet Oncology 2021 cited by 327

  11. Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial

    Authors: Andrew B. Lassman, Stephanie L. Pugh, Tony J. C. Wang, Kenneth Aldape, Hui Gan, Matthias Preusser, Michael A. Vogelbaum, Erik P. Sulman, Minhee Won, Peixin Zhang, Golnaz Moazami, Marian S. Macsai, Mark R. Gilbert, Earle Bain, Vincent Blot, Peter Ansell, Suvajit Samanta, Madan G. Kundu, Terri S. Armstrong, Jeffrey S. Wefel, Clemens Seidel, Filip De Vos, Sigmund Hsu, Andrés F. Cardona, Giuseppe Lombardi, Dmitry Bentsion, Richard A. Peterson, Craig Gedye, Veronique Bourg, Antje Wick, Walter J. Curran, Minesh P. Mehta - Neuro-Oncology 2022 cited by 147

  12. Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials

    Authors: Benjamin M. Ellingson, Martin Bendszus, Jerrold L. Boxerman, Daniel P. Barboriak, Bradley J. Erickson, Marion Smits, Sarah J. Nelson, Elizabeth R. Gerstner, Brian M. Alexander, Gregory Goldmacher, Wolfgang Wick, Michael A. Vogelbaum, Michael Weller, Evanthia Galanis, Jayashree Kalpathy–Cramer, Lalitha Shankar, Paula Jacobs, Whitney B. Pope, Dewen Yang, Caroline Chung, Michael V. Knopp, Soonme Cha, Martin J. van den Bent, Susan Chang, Wai Kuen Yung, Timothy F. Cloughesy, Patrick Y. Wen, Mark R. Gilbert - Neuro-Oncology 2015 cited by 665

  13. Convection-enhanced drug delivery for glioblastoma: a review

    Authors: Randy S. D’Amico, Manish K. Aghi, Michael A. Vogelbaum, Jeffrey N. Bruce - Journal of Neuro-Oncology 2021 cited by 156

  14. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas

    Authors: Nathalie L. Albert, Michael Weller, Bogdana Suchorska, Norbert Galldiks, Riccardo Soffietti, Michelle M. Kim, Christian la Fougère, Whitney B. Pope, Ian Law, Javier Arbizu, Marc C. Chamberlain, Michael A. Vogelbaum, Ben M. Ellingson, J. C. Tonn - Neuro-Oncology 2016 cited by 745

  15. Evidence-based recommendations on categories for extent of resection in diffuse glioma

    Authors: Philipp Karschnia, Michael A. Vogelbaum, Martin J. van den Bent, Daniel P. Cahill, Lorenzo Bello, Yoshitaka Narita, Mitchel S. Berger, Michael Weller, Joerg‐Christian Tonn - European Journal of Cancer 2021 cited by 208

  16. Response Assessment in Neuro-Oncology Clinical Trials

    Authors: Patrick Y. Wen, Susan M. Chang, Martin J. van den Bent, Michael A. Vogelbaum, David R. Macdonald, Eudocia Q. Lee - Journal of Clinical Oncology 2017 cited by 442

  17. Liquid biopsy in gliomas: A RANO review and proposals for clinical applications

    Authors: Riccardo Soffietti, Chetan Bettegowda, Ingo K. Mellinghoff, Katherine E. Warren, Manmeet S. Ahluwalia, John de Groot, Evanthia Galanis, Mark R. Gilbert, Kurt A. Jaeckle, Émilie Le Rhun, Roberta Rudà, Joan Seoane, Niklas Thon, Yoshie Umemura, Michael Weller, Martin J. van den Bent, Michael A. Vogelbaum, Susan M. Chang, Patrick Y. Wen - Neuro-Oncology 2022 cited by 134

  18. Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion

    Authors: Balint Otvos, Daniel J. Silver, Erin E. Mulkearns-Hubert, Alvaro G. Alvarado, Soumya M. Turaga, Mia Dahl Sørensen, Patricia Rayman, William Flavahan, James S. Hale, Kevin B. Stoltz, Maksim Sinyuk, Qiulian Wu, Awad Jarrar, Sung-Hak Kim, Paul L. Fox, Ichiro Nakano, Jeremy N. Rich, Richard M. Ransohoff, James H. Finke, Bjarne Winther Kristensen, Michael A. Vogelbaum, Justin D. Lathia - Stem Cells 2016 cited by 253

  19. Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression

    Authors: Tyler Alban, Defne Bayık, Balint Otvos, Anja Rabljenovic, Lin Leng, Jia-Shiun Leu, Gustavo Roversi, Adam Lauko, Arbaz Momin, Alireza M. Mohammadi, David M. Peereboom, Manmeet S. Ahluwalia, Kazuko Matsuda, Kyuson Yun, Richard Bucala, Michael A. Vogelbaum, Justin D. Lathia - Frontiers in Immunology 2020 cited by 157

  20. Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

    Authors: Martin J. van den Bent, Brigitta G. Baumert, Sara Erridge, Michael A. Vogelbaum, Anna K. Nowak, Marc Sanson, Alba A. Brandes, Paul M. Clément, Jean Français Baurain, Warren Mason, Helen Wheeler, Olivier Chinot, Sanjeev Gill, Matthew Griffin, David Brachman, Walter Taal, Roberta Rudà, Michael Weller, Catherine McBain, Jaap C. Reijneveld, Roelien H. Enting, Damien C. Weber, Thierry Lesimple, Susan Clenton, Anja Gijtenbeek, S. Pascoe, Ulrich Herrlinger, Peter Hau, F. Dhermain, Irene van Heuvel, Roger Stupp, Ken Aldape, Robert B. Jenkins, Hendrikus J. Dubbink, Winand N.M. Dinjens, Pieter Wesseling, Sarah Nuyens, Vassilis Golfinopoulos, Thierry Gorlia, Wolfgang Wick, Johan M. Kros - The Lancet 2017 cited by 397

  21. Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group

    Authors: Raymond Y. Huang, Wenya Linda Bi, Michael Weller, Thomas Kaley, Jaishri O. Blakeley, Ian F. Dunn, Evanthia Galanis, Matthias Preusser, Michael McDermott, Leland Rogers, Jeffrey J. Raizer, David Schiff, Riccardo Soffietti, Jörg-Christian Tonn, Michael A. Vogelbaum, Damien C. Weber, David A. Reardon, Patrick Y. Wen - Neuro-Oncology 2018 cited by 205

  22. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review

    Authors: Leland Rogers, Igor J. Barani, Marc C. Chamberlain, Thomas Kaley, Michael McDermott, Jeffrey Raizer, David Schiff, Damien C. Weber, Patrick Y. Wen, Michael A. Vogelbaum - Journal of neurosurgery 2014 cited by 696

  23. Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma

    Authors: Baisakhi Raychaudhuri, Patricia Rayman, Joanna Ireland, Jennifer S. Ko, Brian I. Rini, Ernest C. Borden, J. Garcia, Michael A. Vogelbaum, James H. Finke - Neuro-Oncology 2011 cited by 356

  24. Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma

    Authors: Sushma Kunwar, Susan M. Chang, Manfred Westphal, Michael A. Vogelbaum, John H. Sampson, Gene H. Barnett, Mark E. Shaffrey, Zvi Ram, J Piepmeier, Michael D. Prados, David Croteau, Christoph Pedain, Pamela Leland, Syed R. Husain, Bharat Joshi, Raj K. Puri, for the PRECISE Study Group - Neuro-Oncology 2010 cited by 481